A recent study has shown that scientists were able to reverse type 1 diabetes in mice by creating a “blended,” or chimeric, immune system. Type 1 diabetes is an autoimmune disease in which the body’s immune system attacks insulin-producing cells in the pancreas, preventing proper regulation of blood sugar levels.
In this study, researchers combined bone marrow stem cells and insulin-producing islet cells from a donor and transplanted them into mice. This process created a hybrid immune system made up of both donor and recipient cells. As a result, the newly formed immune system no longer attacked the insulin-producing cells and instead recognized them as part of the body.
One important aspect of this research is that it avoided the need for long-term immunosuppressive drugs. In most transplant treatments, patients must take these drugs to prevent rejection. However, in this case, the mice maintained normal insulin production without ongoing immune suppression, suggesting a more stable, long-term solution.
This research is significant because it focuses on treating the root cause of type 1 diabetes rather than managing symptoms. Current treatments, such as insulin injections, only help control blood sugar levels. By modifying the immune system, this approach has the potential to provide a long-lasting treatment
From a genetic perspective, this study highlights how cellular and genetic processes shape the immune system's recognition of “self” and “non-self.” Understanding these mechanisms could lead to new treatments for other autoimmune diseases. Although more research is needed, this study represents an important step forward in genetic medicine.
Source:
https://www.livescience.com/health/scientists-cured-type-1-diabetes-in-mice-by-creating-a-blended-immune-system
Additional Link:
https://www.genome.gov/genetics-glossary/Gene-Expression